Sophie Roy
Biographic Data
| ID | 7180858 |
|---|---|
| NAME | Sophie Roy |
| GIVEN NAMES | Sophie |
| FAMILY NAME | Roy |
| SIGNATURE | ROY S |
| AFFILIATIONS | Département de Pharmacologie Médicale Et Toxicologie, Centre d’Addictovigilance, Chu Montpellier, Univ Montpellier, Montpellier, France |
| ORCID | 0000-0002-5196-8834 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Management of Pregabalin Use Disorder
Pregabalin is indicated for the treatment of partial epilepsy, generalized anxiety disorder, and neuropathic pain. The first reports on pregabalin use disorder have been published in Europe in 2010 and notified to the French Addictovigilance Network (FAN) in 2011. The management of pregabalin use disorder is challenging due to the risks associated with the abrupt withdrawal and lack of guidelines. In this retrospective observational study, the ma…
Death toll exceeded 70,000 in Europe during the summer of 2003
Daily numbers of deaths at a regional level were collected in 16 European countries. Summer mortality was analyzed for the reference period 1998–2002 and for 2003. More than 70,000 additional deaths occurred in Europe during the summer 2003. Major distortions occurred in the age distribution of the deaths, but no harvesting effect was observed in the months following August 2003. Global warming constitutes a new health threat in an aged Europe th…
No prominent works on this page.
Death toll exceeded 70,000 in Europe during the summer of 2003
Daily numbers of deaths at a regional level were collected in 16 European countries. Summer mortality was analyzed for the reference period 1998–2002 and for 2003. More than 70,000 additional deaths occurred in Europe during the summer 2003. Major distortions occurred in the age distribution of the deaths, but no harvesting effect was observed in the months following August 2003. Global warming constitutes a new health threat in an aged Europe th…
Management of Pregabalin Use Disorder
Pregabalin is indicated for the treatment of partial epilepsy, generalized anxiety disorder, and neuropathic pain. The first reports on pregabalin use disorder have been published in Europe in 2010 and notified to the French Addictovigilance Network (FAN) in 2011. The management of pregabalin use disorder is challenging due to the risks associated with the abrupt withdrawal and lack of guidelines. In this retrospective observational study, the ma…
Medicine (2 works) · Air Quality and Health Impacts (1 works) · Anxiety (1 works) · Art (1 works) · Climate Change and Health Impacts (1 works) · Demography (1 works) · Generalized anxiety disorder (1 works) · Geography (1 works) · Global Health Care Issues (1 works) · Humanities (1 works)